0001437749-24-003018.txt : 20240202
0001437749-24-003018.hdr.sgml : 20240202
20240202191224
ACCESSION NUMBER: 0001437749-24-003018
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240131
FILED AS OF DATE: 20240202
DATE AS OF CHANGE: 20240202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Smith Jason Drew
CENTRAL INDEX KEY: 0001821479
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38079
FILM NUMBER: 24593469
MAIL ADDRESS:
STREET 1: C/O UROGEN PHARMA LTD.
STREET 2: 400 ALEXANDER PARK DRIVE
CITY: PRINCETON
STATE: NJ
ZIP: 08540
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UroGen Pharma Ltd.
CENTRAL INDEX KEY: 0001668243
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9 HA'TA'ASIYA ST
CITY: RA'ANANA
STATE: L3
ZIP: 4365007
BUSINESS PHONE: 972 9 770 7601
MAIL ADDRESS:
STREET 1: 9 HA'TA'ASIYA ST
CITY: RA'ANANA
STATE: L3
ZIP: 4365007
4
1
rdgdoc.xml
FORM 4
X0508
4
2024-01-31
0001668243
UroGen Pharma Ltd.
URGN
0001821479
Smith Jason Drew
400 ALEXANDER PARK DRIVE
PRINCETON
NJ
08540
1
General Counsel
0
Ordinary Shares
2024-01-31
4
M
0
834
A
19241
D
Ordinary Shares
2024-01-31
4
S
0
417
15.74
D
18824
D
Ordinary Shares
2024-01-31
4
M
0
2500
A
21324
D
Ordinary Shares
2024-01-31
4
S
0
1248
15.74
D
20076
D
Ordinary Shares
2024-01-31
4
M
0
6666
A
26742
D
Ordinary Shares
2024-01-31
4
S
0
3328
15.74
D
23414
D
Restricted Stock Units
2024-01-31
4
M
0
834
0
D
Ordinary Shares
834
0
D
Restricted Stock Units
2024-01-31
4
M
0
2500
0
D
Ordinary Shares
2500
2500
D
Restricted Stock Units
2024-01-31
4
M
0
6666
0
D
Ordinary Shares
6666
13334
D
Restricted Stock Units
2024-01-31
4
A
0
16500
0
A
Ordinary Shares
16500
16500
D
Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.
Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units.
The reporting person was granted RSUs on January 31, 2021 representing 2,500 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2022.
The reporting person was granted RSUs on January 31, 2022 representing 7,500 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2023.
The reporting person was granted RSUs on January 31, 2023 representing 20,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2024.
1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2025, January 31, 2026 and January 31, 2027.
/s/ Jason D. Smith, Attorney-in-Fact
2024-02-02